FFM
ZGNX

Fairmount Funds Management’s Zogenix, Inc. ZGNX Stock Holding History

Fairmount Funds Management’s Portfolio ZGNX Stock Details ZGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,502,259
Closed -$40.7M – 23
2021
Q4 		$40.7M Buy
2,502,259
+560,000
+29% +$8.2M 13.41% 1
2021
Q3 		$29.5M Sell
1,942,259
-28,000
-1% -$437K 10.73% 2
2021
Q2 		$34M Buy
1,970,259
+565,000
+40% +$10.4M 14% 2
2021
Q1 		$27.4M Buy
1,405,259
+424,614
+43% +$8.71M 11.56% 2
2020
Q4 		$19.6M Sell
980,645
-76,230
-7% -$1.56M 7.01% 7
2020
Q3 		$18.9M Buy
1,056,875
+85,000
+9% +$2.08M 8.03% 6
2020
Q2 		$26.3M Hold
971,875
– – 11.71% 3
2020
Q1 		$24M Buy
971,875
+505,000
+108% +$18.4M 14.58% 2
2019
Q4 		$24.3M Buy
+466,875
New +$21.4M 14.75% 1

Fairmount Funds Management's ZGNX Position: Q1 2022 in Review

Fairmount Funds Management sold out of Zogenix, Inc. (ZGNX) in Q1 2022, closing a stake of 2,502,259 shares — an estimated $40.7M sold.

Fairmount Funds Management first reported a position in ZGNX in Q4 2019 and held it in 9 quarters. The position peaked at $40.7M in Q4 2021. 0 funds tracked by Wall St. Rank hold ZGNX as of Q1 2022.

  • Fairmount Funds Management reported no remaining Zogenix, Inc. position as of Q1 2022 after selling out during the quarter.
  • Fairmount Funds Management sold 2,502,259 Zogenix, Inc. shares in Q1 2022, an estimated $40.7M.
  • Fairmount Funds Management first reported a position in Zogenix, Inc. in Q4 2019 and held it in 9 quarters.
  • Fairmount Funds Management's Zogenix, Inc. position peaked at $40.7M in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q1 2022.

Based on Fairmount Funds Management's 13F filing for Q1 2022, filed 16 May 2022.